Patient Investigational New Drug (sIND) applications in the United States SAN FRANCISCO, CA / ACCESS Newswire / September 30, 2025 / Jaguar Health (NASDAQ:JAGX) today announced that Jaguar family ...

The US Food and Drug Administration will review evidence about the safety and efficacy of mifepristone, one of the drugs used ...

The vaccine advisory committee is scheduled to meet next week to review and make recommendations for this fall’s updated ...

Trump administration approves generic version of abortion pill after RFK Jr had FDA review drug’s safety - The drug will now ...

A group of attorneys general are affirming the safety of mifepristone amid a call for the Food and Drug administration to review the abortion medication.

Conservatives have criticized the abortion medication, particularly after it became available through telehealth.

Medical journals and National Comprehensive Cancer Network guidelines rarely publish FDA-identified uncertainties about new ...

The U.S. Food and Drug Administration said that it has begun the daily publication of adverse event reports related to drugs and biological products. This marks a shift from the previous quarterly ...

BALA CYNWYD, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare ...

WASHINGTON (AP) — Shortly before he was forced to resign, the nation’s top vaccine regulator says he refused to grant Health Secretary Robert F. Kennedy Jr.’s team unrestricted access to a tightly ...

The U.S. Food and Drug Administration is changing its policy on who should get COVID-19 shots, potentially limiting access to new vaccine formulations as they enter the market. New and updated jabs ...

Using real-world data from over 300,000 cases, scientists uncovered a significant link between semaglutide and reported vision problems—raising new concerns about the safety profile of this ...